Spis treści:
1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Share buy-back programme schedule from July to December 2026.pdfShare buy-back programme schedule from July to December 2026

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 31 / 2026
Date of issue: 2026-07-20
Short name of the issuer
KRKA
Subject
Start of share buy-back programme
Official market - legal basis
Art. 17 ust. 1 Rozporządzenia MAR – informacje poufne
Unofficial market - legal basis
Contents of the report:
On 9 July 2026, the 32nd Annual General Meeting authorized the Management Board for the acquisition of treasury shares in accordance with the paragraph 1, indent 8 of Article 247 of the Companies Act (ZGD-1).

The company is disclosing that it will commence the acquisition of treasury shares in accordance with this authorization under the following conditions:

* The sole purpose of a share buy-back programme is share capital decrease of the issuer.
* The maximum pecuniary amount allocated to the programme is EUR 251,902,480.
* The maximum number of shares to be acquired is 762,763.
* Duration of the programme is 36 months from the date of the General Meeting authorization.

Shares will be acquired according to the enclosed six-month share buy-back programme schedule until the end of 2026, on the regulated market at the respective market price and on terms that will not affect prevailing market conditions. The company will announce the continuation of the share buy-back programme with a new six-month share buy-back schedule at least 30 days before the expiration of valid schedule.

The public will be regularly informed about these acquisitions of treasury shares.


The notice will be published on the Company's website (www.krka.biz) from 20 July 2026 onwards, for a period of at least 5 years.
Annexes
File Description
Share buy-back programme schedule from July to December 2026.pdf
Share buy-back programme schedule from July to December 2026.pdf		 Share buy-back programme schedule from July to December 2026

Legal framework Type of information
TRANSD Acquisition or disposal of an issuer’s own shares
RegulatoryData
Collection Body PLKNF
Unique data record identifier
Type of submission New (to be used for new information)
Voluntary information flag
Date or period covered [Date or beginning of the period to which the information relates] 2026-07-20
Date or period covered [Date or end of the period to which the information relates] 2026-07-20
Personal data flag
Macierzyste państwo członkowskie, w stosownych przypadkach PL
DocumentReference
Język, w którym przekazano informacje Oryginał (ORIG) czy tłumaczenie (TRAN) Numer referencyjny pliku danych
PL
 ORIG
SubmittingEntity
Submitting entity LEI or Submitting entity name - natural person
RelatedEntity/LegalPerson
Entity LEI Size of the entity Industry sector(s)
549300H9RLRTRTLRUZ73 Large group (acc. NACE): C

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-07-20 Jože Colarič President of the Management Board and CEO
20260720_085827_0225891860_Share_buy-back_programme_schedule_from_July_to_December_2026.pdf

Pobierz